Posts Tagged ‘peginesatide’

Peginesatide in Patients Undergoing Hemodialysis

Posted by Sara Fazio • January 25th, 2013

In two new randomized, controlled studies involving patients undergoing long-term hemodialysis, peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent, was compared with epoetin for the treatment of anemia. The two agents were similarly effective.  Read both the EMERALD study and the PEARL study here. Partial correction of anemia with erythropoiesis-stimulating agents (ESAs) is a cornerstone of therapy… Read More…